| NO. | Name | Years | Detail |
| 1 | Viral vaccine composition, process, and methods of use |
2003 |
A composition for treating or preventing virus-induced infections is described, along with a process of producing the composition and methods of the composition's use. |
| 2 | Drug for AIDS treatment | 2008 |
Raising the T-cell count in an HIV-positive patient having a low T-cell count by orally administering an effective amount of a composition containing a material obtained by treating whole human blood or white cells obtained from HIV-positive patients with cold aqueous carbon dioxide. |
| 3 | Immunotherapy and prevention of autoimmune hepatitis | 2010 | The invention is within the field of immunology and microbiology, more specifically the field of virology and is related to immunotherapy and prophylaxis of hepatitis and autoimmune diseases. |
| 4 | Anti-fungal composition | 2011 | A multivalent fungal vaccine comprising one or more heat-inactivated fungal antigens, wherein at least one fungal antigen is effective in producing an immune response in a host when said vaccine is administered orally at a dose that is sufficient for preventing or treating the fungal disease in said host. |
| 5 | Composition for atherosclerosis, obesity and obesity-related disorders | 2011 | This invention relates to metal-embedded, insoluble hydrolyzed proteins and fragments thereof derived from pooled adipocytes and formulated for oral delivery. |
| 6 | Oral composition and methods for immunotherapy | 2017 | A composition includes a metal chemically bound to at least one heat-denatured tumor antigen and at least one heat-denatured alloantigen. The tumor antigen and/or the alloantigen are hydrolyzed. |
